|
Volumn 16, Issue 8, 2001, Pages 1681-1685
|
Outcome in patients with end-stage renal disease following heart or heart-lung transplantation receiving peritoneal dialysis
a a a a a a,b |
Author keywords
Cardiac function; End stage renal disease; Exit site infection; Heart; Heart lung transplantation; Peritoneal dialysis; Peritonitis
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
PERITONEAL DIALYSIS FLUID;
PREDNISOLONE;
TACROLIMUS;
ADULT;
AGE;
AGED;
ARTICLE;
CLINICAL ARTICLE;
COHORT ANALYSIS;
COMPARATIVE STUDY;
CONGENITAL HEART DISEASE;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DEATH;
DISEASE SEVERITY;
FEMALE;
FOLLOW UP;
HEART DILATATION;
HEART FAILURE;
HEART FUNCTION;
HEART LUNG TRANSPLANTATION;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
ISCHEMIC HEART DISEASE;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
MALE;
PERITONEAL DIALYSIS;
PERITONITIS;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SURVIVAL;
TIME;
TREATMENT FAILURE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
|
EID: 0034863926
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/16.8.1681 Document Type: Article |
Times cited : (37)
|
References (8)
|